To Örebro University

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden 2022 (English)In: Diabetes Therapy, ISSN 1869-6953, E-ISSN 1869-6961, Vol. 13, no 5, p. 1125-1129Article in journal, Letter (Other academic) Published

Place, publisher, year, edition, pages

Springer Healthcare Communications Ltd. , 2022. Vol. 13, no 5, p. 1125-1129

Keywords [en]

Advanced hybrid closed-loop, Cost-effectiveness, Sweden, Type 1 diabetes

National Category

Endocrinology and Diabetes

Identifiers

URN: urn:nbn:se:oru:diva-98541DOI: 10.1007/s13300-022-01252-wISI: 000780770700001PubMedID: 35403952Scopus ID: 2-s2.0-85128112886OAI: oai:DiVA.org:oru-98541DiVA, id: diva2:1651408

Note

Funding agency:

Medtronic International Trading Sàrl

Available from: 2022-04-12 Created: 2022-04-12 Last updated: 2023-12-08Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Jendle, Johan

Search in DiVA

By author/editor

Jendle, Johan

By organisation

School of Medical Sciences

In the same journal

Diabetes Therapy

On the subject

Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle ScholarTotal: 52 hits